Chronic neutrophilic leukemia (CNL), accelerated phase
Showing 1 - 25 of >10,000
Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)
Recruiting
- Myeloproliferative Neoplasm
- +2 more
- Fedratinib Pill
-
Tampa, FloridaMoffitt Cancer Center
Jun 15, 2022
Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -
Recruiting
- Chronic Myeloid Leukemia in Myeloid Blast Crisis
- +3 more
- based decitabine and olverembatinib(HQP1351)chemotherapy
-
Guanzhou, ChinaDepartment of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Decitabine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Venetoclax
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Dec 5, 2022
CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))
Recruiting
- CML, Chronic Phase
- CML, Accelerated Phase
- HS-10382(Part 1: Dose escalation)
- HS-10382(Part 2: Dose expansion)
-
Wuhan, Hubei, ChinaUnion Hospital affiliated to Tongji Medical College of Huazhong
Jan 12, 2023
Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))
Not yet recruiting
- Leukemia
- +12 more
- Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
- (no location specified)
Mar 20, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +4 more
- Eltrombopag Olamine
-
Houston, TexasM D Anderson Cancer Center
Jan 4, 2022
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)
Recruiting
- Acute Myeloid Leukemia
- +6 more
- Orca-Q
-
Gainesville, FloridaUniversity of Florida
Aug 26, 2022
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Neutrophilic Leukemia Trial in United States (Laboratory Biomarker
Completed
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- Chronic Neutrophilic Leukemia
- Laboratory Biomarker Analysis
- +3 more
-
Palo Alto, California
- +6 more
Oct 22, 2020
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +11 more
- Letermovir
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +13 more
- CMVpp65-A*0201 peptide vaccine
- +2 more
-
Duarte, California
- +4 more
Jan 4, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)
Terminated
- Chronic Myeloid Leukemia
- Omacetaxine mepesuccinate
-
Jacksonville, Florida
- +9 more
Nov 6, 2021
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +12 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +2 more
Feb 17, 2022
Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase Trial in Ann Arbor (Vorinostat,
Recruiting
- Hematologic Diseases
- +11 more
- Vorinostat
- +5 more
-
Ann Arbor, MichiganUniversity of Michigan Health System
Dec 2, 2021
Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase
Terminated
- Accelerated Phase Chronic Myelogenous Leukemia (CML)
- +3 more
- Axitinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 17, 2020
Philadelphia Positive Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (STI571
Completed
- Philadelphia Positive Chronic Myeloid Leukemia
- +2 more
- STI571 400 mg
- STI571 600 mg
-
Boston, Massachusetts
- +11 more
Jul 1, 2021
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)
Recruiting
- Acute Myeloid Leukemia
- +6 more
- Hyperbaric oxygen
-
Rochester, New YorkWilmot Cancer Institute, University of Rochester
May 16, 2022
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib + LDE225)
Completed
- Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
- Nilotinib + LDE225
-
Toronto, Ontario, Canada
- +6 more
Dec 6, 2020